EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative outcomes of trans-arterial radioembolization in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease-induced HCC: a retrospective analysis

Christopher Brunson iD, Lucas Struycken, David Schaub, Jacob Ref, Daniel Goldberg, Jack Hannallah, Gregory Woodhead, Shamar Young

Abdominal Radiology · 2024

DOI: 10.1007/s00261-024-04295-8 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Abdominal Radiology, 2024. Verfasst von Christopher Brunson und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of California, 505 Parnassus Avenue, M-391, San Francisco, CA, 94143-0628, USA. Christopher.brunson@ucsf.edu. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Liver Neoplasms, Carcinoma, Hepatocellular, Embolization, Therapeutic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Tumorigenesis in NAFLD/NASH-induced HCC is unique and may affect the effectiveness of trans-arterial radioembolization in this population. The purpose of this study was to retrospectively compare the effectiveness of trans-arterial radioembolization for the treatment of hepatocellular carcinoma (HCC) between patients with non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) and non-NASH/NAFLD liver disease. Materials and methods Consecutive patients with HCC who underwent TARE at a single academic institution were retrospectively reviewed. Outcome measures including overall survival (OS), local progression-free survival (PFS), and hepatic PFS as assessed by modified response evaluation criteria in solid tumors (mRECIST) were recorded. Kaplan–Meier and Cox proportional hazard models were utilized to compare progression-free survival and overall survival.

Results

138 separate HCCs in patients treated with TARE between July 2013 and July 2022 were retrospectively identified. Etiologies of HCC included NASH/NAFLD (30/122, 22%), HCV (52/122, 43%), alcoholic liver disease (25/122, 21%), and combined ALD/HCV (14/122, 11%). NASH/NAFLD patients demonstrated a significantly higher incidence of type 2 diabetes mellitus ( p < 0.0001). There was no significant difference in overall survival ( p = 0.928), local progression-free survival ( p = 0.339), or hepatic progression-free survival between the cohorts ( p = 0.946) by log-rank analysis. When NASH/NAFLD patients were compared to all combined non-NASH/NAFLD patients, there was no significant difference in OS (HR 1.1, 95% C.I. 0.32–3.79, p = 0.886), local PFS (HR 1.2, 95% C.I. 0.58–2.44, p = 0.639), or hepatic PFS (HR 1.3, 95% C.I. 0.52–3.16, p = 0.595) by log-rank analysis.

Conclusion

TARE appears to be an equally effective treatment for NASH/NAFLD-induced HCC when compared to other causes of HCC. Further studies in a larger cohort with additional subgroup analyses are warranted. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseLiver NeoplasmsCarcinoma, HepatocellularEmbolization, TherapeuticHumansRetrospective StudiesMaleFemaleMiddle AgedAgedYttrium RadioisotopesTreatment OutcomeAdultRadiopharmaceuticals

Stichwörter der Autor:innen

Fatty liver diseaseHepatocellular carcinomaRadiation dosimetryYttrium-90

Substanzen

Yttrium RadioisotopesRadiopharmaceuticals

Autor:innen und Institutionen

  • University of California, 505 Parnassus Avenue, M-391, San Francisco, CA, 94143-0628, USA. Christopher.brunson@ucsf.edu.
  • Department of Medical Imaging, University of Arizona Health Sciences, Tucson, USA.
  • University of Arizona Health Sciences, Tucson, USA.

ORCID-Profile: Christopher Brunson

Zitieren

APA

Brunson, C., Struycken, L., Schaub, D., Ref, J., Goldberg, D., Hannallah, J., Woodhead, G., & Young, S. (2024). Comparative outcomes of trans-arterial radioembolization in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease-induced HCC: a retrospective analysis. Abdominal Radiology. https://doi.org/10.1007/s00261-024-04295-8

Vancouver

Brunson C, Struycken L, Schaub D, Ref J, Goldberg D, Hannallah J, et al. Comparative outcomes of trans-arterial radioembolization in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease-induced HCC: a retrospective analysis. Abdominal Radiology. 2024. doi:10.1007/s00261-024-04295-8

BibTeX
@article{Brunson2024,
  author = {Brunson, Christopher and Struycken, Lucas and Schaub, David and Ref, Jacob and Goldberg, Daniel and Hannallah, Jack and Woodhead, Gregory and Young, Shamar},
  title = {Comparative outcomes of trans-arterial radioembolization in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease-induced HCC: a retrospective analysis},
  journal = {Abdominal Radiology},
  year = {2024},
  doi = {10.1007/s00261-024-04295-8}
}
Kostenlos starten →